Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects-Reference-Cited by-同舟云学术

Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects

Published:2019-02 Issue:9 Volume:26 Page:2494-2508.e7
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Ooi Jolene,Langley Sarah R.,Xu Xiaohong,Utami Kagistia H.,Sim Bernice,Huang Yihui,Harmston Nathan P.,Tay Yi Lin,Ziaei Amin,Zeng Ruizhu,Low Donovan,Aminkeng Folefac,Sobota Radoslaw M.,Ginhoux Florent,Petretto Enrico,Pouladi Mahmoud A.

Funder

Agency for Science, Technology and Research

IMCB and IMB Strategic Positioning Fund

Young Investigator Grant

NMRC

SINGA

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference62 articles.

1. Genetic correction of Huntington’s disease phenotypes in induced pluripotent stem cells;An;Cell Stem Cell,2012

2. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease;Andrew;Nat. Genet.,1993

3. Onset and rate of striatal atrophy in preclinical Huntington disease;Aylward;Neurology,2004

4. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington’s disease;Bae;Neuron,2005

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Huntingtin is an RNA binding protein and participates in NEAT1 -mediated paraspeckles;Science Advances;2024-07-19

2. Generation of three isogenic gene-edited Huntington’s disease human embryonic stem cell lines with DOX-inducible NGN2 expression cassette in the AAVS1 safe locus;Stem Cell Research;2024-06

3. Huntingtin loss-of-function contributes to transcriptional deregulation in Huntington’s disease;2024-05-20

4. Huntingtin polyglutamine expansions misdirect axonal transport by perturbing motor and adaptor recruitment;2024-04-12

5. Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo;Progress in Neurobiology;2024-04